{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Physical+Activity+Level&page=73", "query": { "intervention": "Physical Activity Level", "page": 73 }, "page_size": 10 }, "pagination": { "page": 73, "page_size": 10, "total_count": 1729, "total_pages": 173, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Physical+Activity+Level&page=74&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Physical+Activity+Level&page=72&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T10:11:54.271Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04013412", "title": "Dietary Restriction in Vascular Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vascular Diseases", "Surgery" ], "interventions": [ { "name": "Protein-Calorie Restriction", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2018-12-31", "completion_date": "2020-03-31", "has_results": false, "last_update_posted_date": "2020-09-25", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04013412" }, { "nct_id": "NCT03910881", "title": "Technology-enabled Patient Support System for Self-management of CF", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Open-platform patient support system (PSS) app", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 40, "start_date": "2020-02-18", "completion_date": "2021-01-31", "has_results": false, "last_update_posted_date": "2021-05-04", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03910881" }, { "nct_id": "NCT01277367", "title": "Vitality Health Incentives for Physical Activity", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Discovery Vitality base program", "type": "BEHAVIORAL" }, { "name": "Communication", "type": "BEHAVIORAL" }, { "name": "Charitable Incentive", "type": "BEHAVIORAL" }, { "name": "Prize Draw Incentive", "type": "BEHAVIORAL" }, { "name": "Direct Payment", "type": "BEHAVIORAL" }, { "name": "Free Choice", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2010-05", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2016-08-19", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01277367" }, { "nct_id": "NCT03064971", "title": "Enhancing Quitline Services for African American Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tobacco Use Cessation" ], "interventions": [ { "name": "Standard Care", "type": "BEHAVIORAL" }, { "name": "smoking cessation DVD", "type": "BEHAVIORAL" }, { "name": "PTF DVD", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1050, "start_date": "2017-05-22", "completion_date": "2020-06-24", "has_results": false, "last_update_posted_date": "2020-08-19", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03064971" }, { "nct_id": "NCT03312764", "title": "Preventing Diabetes With Digital Health and Coaching", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "PreDiabetes" ], "interventions": [ { "name": "Online diabetes prevention program", "type": "BEHAVIORAL" }, { "name": "Standard Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Omada Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 598, "start_date": "2017-11-01", "completion_date": "2020-08-31", "has_results": false, "last_update_posted_date": "2021-02-23", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03312764" }, { "nct_id": "NCT04682431", "title": "A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor", "Gynecologic Cancer", "Breast Cancer", "Colorectal Cancer", "Gastric Adenocarcinoma", "Lung Adenocarcinoma", "Pancreatic Cancer", "Head and Neck Cancer" ], "interventions": [ { "name": "PY159 Single agent dose level 1", "type": "DRUG" }, { "name": "PY159 Single agent dose level 2", "type": "DRUG" }, { "name": "PY159 Single agent dose level 3", "type": "DRUG" }, { "name": "PY159 Single agent dose level 4", "type": "DRUG" }, { "name": "PY159 Single agent dose level 5", "type": "DRUG" }, { "name": "PY159 Single agent dose level 6", "type": "DRUG" }, { "name": "PY159 Single agent dose level 7", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 1", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 2", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 3", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose level 4", "type": "DRUG" }, { "name": "PY159 Single agent dose expansion cohort", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 1", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 2", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 3", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 4", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 5", "type": "DRUG" }, { "name": "PY159/Pembrolizumab Combination dose expansion cohort 6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ikena Oncology", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 127, "start_date": "2020-11-10", "completion_date": "2023-08-31", "has_results": false, "last_update_posted_date": "2024-03-22", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 17, "location_summary": "Los Angeles, California • San Francisco, California • Santa Monica, California + 14 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04682431" }, { "nct_id": "NCT06352372", "title": "Safety and Efficacy of tPBM for Epileptiform Activity in Autism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorder", "EEG With Periodic Abnormalities", "Epilepsy", "Neurodevelopmental Disorders", "Neurological Disorder" ], "interventions": [ { "name": "noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Richard Frye", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "4 Years to 16 Years" }, "enrollment_count": 6, "start_date": "2024-07-01", "completion_date": "2026-02-10", "has_results": true, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06352372" }, { "nct_id": "NCT02780128", "title": "Next Generation Personalized Neuroblastoma Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuroblastoma", "Cancer" ], "interventions": [ { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Next Generation Sequencing", "type": "GENETIC" }, { "name": "Tumor Scans", "type": "PROCEDURE" }, { "name": "Bone marrow Tests", "type": "PROCEDURE" }, { "name": "Physical Exam", "type": "OTHER" }, { "name": "Eye Exam", "type": "OTHER" }, { "name": "Labs", "type": "OTHER" }, { "name": "Pregnancy Test", "type": "OTHER" }, { "name": "Interviews", "type": "BEHAVIORAL" }, { "name": "ECG", "type": "OTHER" }, { "name": "Echocardiogram", "type": "OTHER" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Ceritinib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "GENETIC", "OTHER", "BEHAVIORAL", "DRUG" ], "sponsor": "Yael P Mosse", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 66, "start_date": "2016-07", "completion_date": "2022-08", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02780128" }, { "nct_id": "NCT05120544", "title": "Expanding Technology-Enabled Nurse Delivered Chronic Disease Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2", "Hypertension" ], "interventions": [ { "name": "EXTEND Plus", "type": "BEHAVIORAL" }, { "name": "EXTEND", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "30 Years to 75 Years" }, "enrollment_count": 220, "start_date": "2022-04-21", "completion_date": "2025-08-13", "has_results": true, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05120544" }, { "nct_id": "NCT04931836", "title": "The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Overweight", "Overweight and Obesity", "PreDiabetes", "Type 2 Diabetes", "Type 2 Diabetes Mellitus", "Type 2 Diabetes Mellitus in Obese" ], "interventions": [ { "name": "Physical Activity Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "30 Years to 64 Years" }, "enrollment_count": 77, "start_date": "2021-07-29", "completion_date": "2023-11-30", "has_results": true, "last_update_posted_date": "2025-06-13", "last_synced_at": "2026-11-12T10:11:54.271Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04931836" } ] }